LABD Fund Description
The Direxion Daily S&P Biotech Bear -3x Shares ETF provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.
LABD Factset Analytics Insight
LABD is a daily leveraged inverse (-3x) bet on the S&P Biotechnology Select Industry Index, an index tracked in unleveraged form by SSgA's XBI. In this indexing choice, it breaks with ProShares rival BIS, which proves -2x exposure to the same NASDAQ Biotechnology Index tracked by wildly popular IBB, from iShares. Besides the extra leverage factor that LABD applies compared to BIS, LABD's index arguably offers slightly purer exposure to biotech as we define it. LABD provides its exposure through a portfolio of swaps that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path dependent, and is likely to be different from -3x the return of the index for the same period. This makes LABD suitable primarily for short-term traders, who will find ample volume and modest spreads. LABD's expense ratio is typical of leverage products, but not a major factor for such a short-term tool.
LABD Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of LABD. LABD is rated a N/A out of 5.